About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, November 20th, 2017

The QualityStocks
Daily Stock List


Noble Roman's, Inc. (NROM)

FeedBlitz, Marketbeat, The Bowser Report, StockOodles, Wall Street Resources, TaglichBrothers, and SmallCapVoice reported on Noble Roman's, Inc. (NROM), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. The Company’s business model comprises three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. The Company franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, Tuscano’s Italian Style Subs, and Noble Roman's Craft Pizza & Pub trade names. Noble Roman's is based in Indianapolis, Indiana.

The Company opened its first location in February 2017 for its new-generation, stand-alone pizzeria concept named “Noble Roman's Craft Pizza & Pub”. The initial location opened in 4,000 square feet of the newly constructed Monon Marketplace on Main Street/Highway 32 across from Grand Park in Westfield, Indiana.

Noble Roman’s Craft Pizza & Pub features two styles of hand-crafted, made-from-scratch pizzas with a selection of 40 different toppings, cheeses, and sauces. In addition, beer and wine is featured, with 16 different beers on tap.

Noble Roman's has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. Moreover, it has awarded franchise and/or license agreements in Puerto Rico, the Bahamas, Italy, Canada, and the Dominican Republic.

Concerning Non-Traditional Venues, these are typically located in a host facility whose primary business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit. Example kinds of locations include Bowling Centers; Convenience Stores; Walmart®/Retail Centers; Hospitals; Entertainment Facilities; and Military Bases.

Regarding Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the types of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Grocery Take-n-Bake Licensing involves licensing of individual Groceries to sell Noble Roman’s Pizza. This is a component program using Noble Roman’s ingredients, in which delis assemble pizzas from standard Noble Roman’s ingredients.

Last week, Noble Roman's announced highlights from the most recent three-month and nine-month periods ended September 30, 2017. For the three-month period ended September 30, 2017, versus the comparable period ended in 2016; Total Revenue was $2.5 million versus $2.0 million. This represents a 24.3 percent increase. Operating Income was $761,000 versus $856,000. Net Loss was $1.2 million, or $.06 per basic share, versus a Net Loss of $993,000, or $.05 per basic share.

The first unit of Noble Roman's Craft Pizza & Pub (CPP) concept continues to surpass Company Management's pre-opening expectations. For the eight months that the unit has been open (February through September), Sales were $1.22 million net of discounts and promotions, with a Net Income of $321,000.

Noble Roman's reiterated that the second CPP location was on schedule to open on November 17, 2017. The third CPP is scheduled to open mid-January, 2018. The Company is also considering an array of locations for its fourth location to open in early spring 2018.

Noble Roman's, Inc. (NROM), closed Monday's trading session at $0.5999, up 3.43%, on 3,743 volume with 4 trades. The average volume for the last 60 days is 34,220 and the stock's 52-week low/high is $0.3562/$0.8828.

VerifyMe, Inc. (VRME)

Wall Street Mover and SmallCapVoice reported earlier on VerifyMe, Inc. (VRME), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

VerifyMe, Inc. is a pioneer in patented physical, cyber, and biometric technologies, which prevent identity theft, counterfeiting, and fraud. The Company is a high-technology solutions enterprise in the field of authenticating products and people. VerifyMe pursues innovation via the development of patented products, proprietary technologies, and the creation of strategic alliances.

Listed on the OTC Markets Group’s OTCQB, the Company previously went by the name LaserLock Technologies, Inc. It changed its corporate name to VerifyMe, Inc. in July of 2015. VerifyMe is headquartered in New York, New York.

VerifyMe provides advanced fraud prevention technologies to pharmaceutical companies, high-end retailers, the gaming industry, and governments around the world. VerifyMe™ ID services integrate biometrics to protect corporate and consumer integrity.

VerifyMe’s physical technology authenticates products, documents, as well as currency with a set of proprietary security inks and pigments. The Company markets a comprehensive patent portfolio. This includes patents for protecting material goods, products, and packaging. Its digital technology authenticates people through performing strong, multi-factor verification through its patented digital platform.

VerifyMe™ provides a broad array of technologies to authenticate products and packaging. This is from proprietary security pigments to custom track and trace solutions. VerifyMe™ can authenticate individuals using facial recognition, fingerprint, voice and retina scanning, swipe pattern recognition, location detection and approved IP detection.

VerifyMe™ ID Services replaces passwords and PINs with intuitive, user-friendly, multi-factor authentication. The Company’s SecureLight™ can immediately change color under compact fluorescent light and LED light sources. Additionally, its SecureLight+™ combines the covert and overt characteristics of RainbowSecure™ and SecureLight™ into a single solution.

RainbowSecure™ is a proprietary, customizable, covert anti-counterfeiting solution. It appears invisible to the human eye. Nonetheless, RainbowSecure™ can be activated utilizing authentication devices specifically tuned to the unique frequency of each batch of ink.

This past September, VerifyMe and the Indigo Division of HP, Inc. announced that they signed a five-year global contract. The companies will incorporate VerifyMe's pigment products with HP Indigo's ElectroInk to be used for packaging, label authentication, anti-counterfeiting and covert item level serialization for supply chain and distribution security.

HP will have its worldwide machines loaded with VerifyMe's RainbowSecure™ inks. This will enable roughly 4,500 HP Indigo digital presses worldwide to seamlessly incorporate authentication measures.

VerifyMe, Inc. (VRME), closed Monday's trading session at $0.115, up 9.52%, on 15,200 volume with 5 trades. The average volume for the last 60 days is 119,948 and the stock's 52-week low/high is $0.035/$0.27.

NanoFlex Power Corp. (OPVS)

MarketWatch, InvestorsHub, and Morningstar reported earlier on NanoFlex Power Corp. (OPVS), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, NanoFlex Power Corp. engages in the research, development, and commercialization of advanced configuration solar technologies. These technologies enable innovative thin-film solar cell implementations. The Company believes these will be industry-leading efficiencies, light weight, flexible, and low total system cost. NanoFlex Power is based in Scottsdale, Arizona.

The Company’s sponsored research programs at USC, Michigan, and Princeton University have resulted in a wide-ranging portfolio of issued and pending patents, internationally, covering flexible, thin-film photovoltaic technologies. Its sponsored research programs with the University of Southern California and the University of Michigan have resulted in an Intellectual Property (IP) portfolio comprising greater than 700 issued or pending patents globally.

NanoFlex Power is part of a consortium that was awarded a $6.5 million contract from the Army Research Laboratory's Army Research Office. The contract is to develop high power, flexible, and lightweight solar modules for portable power applications with more than double the power of existing flexible solar modules within the same footprint at a competitive procurement cost on a dollars per Watt basis. The consortium consists of NanoFlex Power, SolAero Technologies, the University of Michigan (UM), and the University of Wisconsin (UW).  

NanoFlex Power’s research programs have produced two solar thin film technology platforms. These are: Gallium Arsenide (GaAs) thin film technology for high power applications and organic photovoltaic (OPV) technology for applications requiring high quality aesthetics. This includes semi-transparency and tinting and ultra-flexible form factors.

The targeting of these technologies is at specific extensive applications. These include mobile and off-grid power generation; building applied photovoltaics (BAPV); and building integrated photovoltaics (BIPV).

Furthermore, these include space vehicles and unmanned aerial vehicles (UAVs); and semi-transparent photovoltaic windows or glazing. They also include ultra-thin solar films or paints for automobiles or other consumer applications.

NanoFlex Power’s sponsored research agreements provide it with the exclusive international license and right to sublicense any and all IP resulting from the related research and development (R&D) efforts at the above-mentioned universities.

NanoFlex Power entered into a license agreement with SolAero Technologies Corp. For the last two years, the Company and SolAero have partnered to validate NanoFlex's patented, non-destructive epitaxial lift-off (ND-ELO) process and related technologies in SolAero's ultra-high efficiency solar cells. SolAero is an international leader in high performance photovoltaics for space and terrestrial applications. SolAero is a foremost manufacturer of high efficiency solar cells.

NanoFlex Power has the exclusive worldwide rights to license, sublicense, and bring its own products to market using ND-ELO technology. ND-ELO technology has the potential to lessen compound semiconductor production costs by more than 40 percent through enabling reuse of the expensive wafer substrate.

NanoFlex Power Corp. (OPVS), closed Monday's trading session at $0.48, up 20.00%, on 38,494 volume with 16 trades. The average volume for the last 60 days is 14,186 and the stock's 52-week low/high is $0.17/$1.50.

AntriaBio, Inc. (ANTB)

Ceocast News, BUYINS.NET, and PennyStocks24 reported previously on AntriaBio, Inc. (ANTB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AntriaBio, Inc. is a biopharmaceutical company centering on developing novel extended release therapies. It develops novel extended release therapies through combining proprietary formulation and manufacturing capabilities with well-known molecules to substantially improve standards of care. Fundamentally, AntriaBio specializes in the development of innovative drug therapies for patients with diabetes and metabolic diseases. AntriaBio is based in Louisville, Colorado.

The Company develops unique approaches to fulfill unmet clinical needs through applying its formulation capabilities to improve existing therapies. Its lead product candidate is AB101. This is an injectable once-weekly basal insulin for type 1 and type 2 diabetes. AB101 addresses a $10 billion market where the present standard of care is a once-daily basal insulin injection.

AB101 is formulated from human recombinant insulin. This is different from existing basal insulin replacement therapies that use synthetic insulin analogues. AB101 is currently in preclinical development.

AB101 is to be administered by subcutaneous injection. The design of the formulation is to release human insulin slowly and uniformly over a period of about one week without an adverse initial burst of insulin.

AntriaBio successfully completed a series of in vitro and multi-species animal pharmacology studies for AB101. The studies assessed the receptor pharmacology, pharmacokinetics, and pharmacodynamics of AB101. The studies support potential proof-of-concept for a once-weekly basal insulin in patients.

Another product candidate in the Company’s product development pipeline is AB301. As a potential treatment for patients with type 2 diabetes, AB301 is a weekly injectable combination of a pegylated human glucagon-like peptide-1 (GLP-1) agonist and AB101, AntriaBio’s basal insulin lead product candidate.

AntriaBio announced in May of this year that it formally engaged Prosciento to conduct AntriaBio's first-in-human clinical study of AB101, the once-weekly basal insulin for patients with diabetes mellitus. Prosciento is a clinical research organization (CRO) specializing in diabetes mellitus and other metabolic diseases.

AntriaBio has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for AB101. In July of this year, AntriaBio announced the dosing of the first patient in a Phase 1 first-in-human clinical trial of its lead product candidate, AB101. The Phase 1 clinical trial is a first-in-human single ascending dose study to assess the safety and tolerability, pharmacokinetics and pharmacodynamics of AB101 in patients with type 1 diabetes mellitus.

The first study part will be sequential cohort dose ranging of AB101. An optional second study part will compare one or more tested doses of AB101 from part 1 to active comparator Lantus® (insulin glargine).

AntriaBio, Inc. (ANTB), closed Monday's trading session at $0.93, down 7.00%, on 3,410 volume with 6 trades. The average volume for the last 60 days is 3,350 and the stock's 52-week low/high is $0.625/$1.40.

Energy Services of America Corp. (ESOA)

Marketbeat and Real Pennies reported earlier on Energy Services of America Corp. (ESOA), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Energy Services of America Corp. provides contracting services for energy related companies. Currently, the Company mainly serves the gas, petroleum, power, chemical, and automotive industries. However, it does some other incidental work including water and sewer projects. Energy Services of America is the parent company of C.J. Hughes Construction Company and Nitro Electric Company. Energy Services of America is based in Huntington, West Virginia.

The Company builds, but does not own, natural gas pipelines for its customers, which are part of interstate and intrastate pipeline systems that move natural gas from producing areas to consumption areas, and also constructing and replacing gas line services to individual customers of the different utility companies. Most of its customers are in West Virginia, Virginia, Ohio, Pennsylvania, and Kentucky.

Regarding the gas industry, Energy Services of America primarily engages in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It engages in the construction of interstate and intrastate pipelines, with an emphasis on intrastate pipelines.

Pertaining to the oil industry, the Company provides an assortment of services relating to pipeline, storage facilities, and plant work. For the power, chemical, and automotive industries, it provides a complete range of electrical and mechanical installations and repairs. This includes substation and switchyard services, site preparation, equipment setting, pipe fabrication and installation, packaged buildings, transformers, and other ancillary work in regard to these.

Energy Services of America’s other services include liquid pipeline construction, pump station construction, production facility construction, and water and sewer pipeline installations. It also includes varied maintenance and repair services and other services related to pipeline construction.

This past August, Energy Services of America announced the filing of its quarterly report on Form 10-Q for the quarter ended June 30, 2017. The Company earned Revenues of $35.7 million and $98.6 million for the three and nine months ended June 30, 2017, respectively.

Gross Loss was $1.4 million for the three months ended June 30, 2017. Gross Profit was $4.8 million for the nine months ended June 30, 2017.

Net Loss available to common shareholders was $1.9 million and $1.2 million for the three and nine months ended June 30, 2017, respectively. Energy Services of America had a negative adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) of $2.2 million (($0.15) per share) for the three months ended June 30, 2017 and an adjusted EBITDA of $1.3 million ($0.09 per share) for the nine months ended June 30, 2017.

Energy Services of America Corp. (ESOA), closed Monday's trading session at $1.07, up 7.00%, on 5,869 volume with 6 trades. The average volume for the last 60 days is 5,324 and the stock's 52-week low/high is $0.94/$1.92.

Graphite One Resources, Inc. (GPHOF)

OTC Markets, Investing News, and MarketWatch reported earlier on Graphite One Resources, Inc. (GPHOF), and we report on the Company today, here at the QualityStocks Daily Newsletter.

Graphite One Resources, Inc. involves in the acquisition, exploration, and evaluation of graphitic mineral properties in the U.S. The Company continues to develop its Graphite One Project, where it could potentially become an American producer of high grade Coated Spherical Graphite (CSG) that is integrated with a domestic graphite resource. Graphite One Resources has its head office in Vancouver, British Columbia. The Company’s shares trade on the OTCQB.

Graphite is an important material for electric vehicle batteries and energy storage systems. At present, the United States is 100 percent import-dependent for its graphite supply.

The Company’s Graphite One Project is proposed as a vertically integrated enterprise to mine, process, and manufacture high grade CSG primarily for the lithium-ion (Li-ion) electric vehicle battery market. As stated in Graphite One Resources’ Preliminary Economic Assessment (PEA), potential graphite mineralization mined from its Graphite Creek Property is expected to be processed into concentrate at a graphite processing plant. This proposed processing plant would be located on the Graphite Creek Property on the Seward Peninsula, roughly 60 kilometers north of Nome, Alaska.

CSG and other value-added graphite products would likely be manufactured from the concentrate at the Company’s proposed graphite product manufacturing facility, the location of which is the subject of more study and analysis. Graphite One Resources’ aim is to make a production decision on the Graphite One Project upon the completion of a Feasibility Study (FS).

Graphite One Resources announced in February 2017 that it entered into a Memorandum of Understanding (MOU) with the Alaska Industrial Development and Export Authority (AIDEA) to explore opportunities to collaborate on the development of the Graphite One Project.

Graphite One Resources has received a site assessment report for its advanced-materials graphite refinery facility prepared by AIDEA (the AIDEA Report) with cooperation from the Alaska Department of Commerce, Community and Economic Development and the Department of Natural Resources.

The AIDEA Report is the first product of the MOU entered into by AIDEA and Graphite One announced in February 2017. The four potential locations identified in the AIDEA Report are Homer, Kenai, Port Mackenzie, and Seward. Graphite One notified AIDEA of its interest in coordinating in-depth site assessments with the communities identified in the AIDEA Report.

Graphite One Resources engaged TRU Group, Inc to complete the Graphite One Project PEA. The final report was released February 2, 2017.

This report concluded that, based on exploration drilling and test work completed to date, and also various documented assumptions, an estimated 44 million tonnes of graphite mineralization at 7 percent Cg would be available to be mined and, when processed in the Processing Plant at a recovery rate of 80 percent Cg, supports a project life of 40 years producing 60,000 tonnes per year of graphite concentrate at 95 percent Cg, once full production in Year 6 is reached.

Graphite One Resources, Inc. (GPHOF), closed Monday's trading session at $0.0363, down 1.89%, on 67,630 volume with 5 trades. The average volume for the last 60 days is 121,544 and the stock's 52-week low/high is $0.029/$0.09.

Plastic2Oil, Inc. (PTOI)

OTC Markets Group, Investors Hub, Investors Hangout, and MarketWatch reported earlier on Plastic2Oil, Inc. (PTOI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Plastic2Oil, Inc. is a North American fuel company listed on the OTC Markets Group’s OTCQB. Plastic2Oil provides technology to recycle waste plastic into liquid fuels, and dirty fuel into clean diesel. The Company’s technology can deliver economic and environmental benefits through replacing refined fuels and diverting waste plastic from landfills. Plastic2Oil transforms unsorted, unwashed waste plastic into ultra-clean, ultra-low sulphur fuel without the necessity for refinement.

A clean energy enterprise, Plastic2Oil has its corporate office in Niagara Falls, New York. The Company previously went by the name JBI, Inc. It changed its name to Plastic2Oil, Inc. in August of 2014.

The Company’s patent-pending Plastic2Oil® (P2O®) process is a commercially viable, scalable proprietary process. The design of it is to provide fast economic benefit for industry, communities, and also government organizations with waste plastic recycling challenges. Additionally, Plastic2Oil’s dedication is to the creation of green employment opportunities and a decrease in the cost of plastic recycling programs for businesses and municipalities.

The Company is partnering with businesses and municipalities that collect waste plastics. This waste plastic is usually delivered to independent Material Recycling Facilities (MRFs), where it is frequently sent to landfills. Plastic2Oil’s goal is to help redirect these waste plastic streams, preventing them from entering local landfills.

Concerning plastic feedstock supply, the Company’s feedstock sources chiefly include post-commercial and industrial waste plastic. The P2O processor accepts unwashed, unsorted waste plastic, composites and commingled materials, which are difficult to dispose of and are usually found in industrial waste streams. Plastic2Oil believes its P2O process provides a cost-effective, environmental solution for communities and businesses.

Regarding the Company’s P2O technology, the processor requires only 4,500 sq. ft. of operating space. The height requirement is roughly 20 ft. The processor is highly automated with a very low operator to processor ratio.

In addition, the modular design allows for easy deployment. Moreover, optimal feedstock includes polyethylene and polypropylene.

The design of the P2O processor is to use minimal amounts of external energy. Only 53 kWh of electricity is needed to run the fans, pumps, as well as small motors. No electricity is used in the transformation of the plastic to fuel. Natural gas is only used on start-up to heat the reactor.

Plastic2Oil, Inc. (PTOI), closed Monday's trading session at $0.035, up 16.67%, on 76,563 volume with 8 trades. The average volume for the last 60 days is 50,773 and the stock's 52-week low/high is $0.06/$0.006.


The QualityStocks
Company Corner



The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $0.903, up 1.69%, on 384,775 volume with 334 trades. The stock’s average daily volume over the past 60 days is 302,722 and its 52-week low/high is $0.6171/$1.25.

NetworkNewsWire Editorial Coverage: The Canadian government’s commitment to legalize recreational cannabis in July 2018 is touted as an opportunity for investors to profit from the ongoing green blitz. Gearing up for the anticipated spike in consumer demand, cannabis-related businesses are lining up steady sources of supply from the country’s licensed producers (LPs). The alcohol and tobacco industries are also preparing to get their hands on the plush opportunities of legalized recreational cannabis. One of Canada’s earliest licensed cannabis producers, ABcann Global Corp. (OTCQB: ABCCF) (TSX.V: ABCN) (ABCCF Profile), is well-positioned to capitalize on the market’s expansion with its computer-controlled growing platform that helps it produce more than 250 grams of cannabis per square foot each year, placing it among the highest yields within the Canadian sector.

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global Blog

ABcann Global News:

Coming Cannabis Recreational Demand in Canada Triggers Massive Investment

ABcann Global Strengthens Board and Executive Team

NetworkNewsWire Announces Publication on Anticipated Demand as Canada Prepares for Legalization of Recreational Marijuana

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $0.576, up 1.53%, on 76,113 volume with 54 trades. The stock’s average daily volume over the past 60 days is 68,972, and its 52-week low/high is $0.3148/$0.67.

First Cobalt Corp. (FTSSF) is pleased to announce Cobalt One Ltd. (ASX:CO1) shareholders have approved the merger with First Cobalt, with 99.995% of votes cast in favor. Trent Mell, President & Chief Executive Officer, commented: "We are one step closer to creating the largest pure play cobalt company in the world. We look forward to seeing First Cobalt shares trade on the ASX, as this dual listing will bring a much larger shareholder base and added liquidity."

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

Cobalt One Shareholders Overwhelmingly Approve Merger with First Cobalt

First Cobalt Begins Assessment of Economic Potential of Historic Muckpile Material

NetworkNewsWire Releases Exclusive Audio Interview with First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.4901, up 2.10%, on 18,515 volume with 28 trades. The stock’s average daily volume over the past 60 days is 107,722 and its 52-week low/high is $0.40/$2.75.

ChineseInvestors.com (CIIX) said today that its foreign enterprise, CBD Biotechnology Co. Ltd., has partnered with The Godfather of Beauty for the launch of its "CBD Magic Hemp Series" skincare line on China's largest e-commerce retailer Alibaba. There were over 40,000 views during the first broadcast of "China Taobao Live Broadcasting Celebrity Show," with more than 91 units from the CBD Magic Hemp Series skincare line purchased minutes into the launch. "The success of the initial launch of the CBD Magic Hemp Series skincare line on Taobao solidifies our belief that Chinese consumers recognize that the anti-inflammatory agents and anti-oxidants contained in hemp-extract can have positive effects on the skin," ChineseInvestors.com CEO Warren Wang stated in the news release. To view the full article, visit: http://cnw.fm/ZpO5S

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News:

CannabisNewsBreaks – ChineseInvestors.com, Inc.’s (CIIX) CBD Biotechnology Enterprise Partners with Chinese Beauty Influencer to Launch CBD Magic Hemp Series Skincare Line on Taobao

ChineseInvestors.com, Inc. (CIIX) Launches OptHemp Line Through Its Subsidiary, ChineseHempOil.com On Amazon.com (NASDAQ: AMZN) For Singles Day 2017

ChineseInvestors.com, Inc. Announces that its Subsidiary ChineseHempOil.com, Inc. Launched its OptHemp Product Line on Amazon for Singles Day 2017

AV1 Group, Inc. (AVOP)

The QualityStocks Daily Newsletter would like to spotlight AV1 Group, Inc. (AVOP). Today, AV1 Group, Inc. closed trading at $0.036, up 1.41%, on 38,504 volume with 7 trades. The stock’s average daily volume over the past 60 days is 217,785 and its 52-week low/high is $0.017/$0.314.

AV1 Group, Inc. (AVOP), today announces that the Company's minority-owned subsidiary, Intelligent Lighting Solutions, Inc., by virtue of its certification as a "Small Business Owned" company in the State of California, has successfully landed an additional order for cutting-edge lighting fixtures at a State of California Prison. These custom lighting solutions will serve to illuminate and protect the facility's perimeters.

AV1 Group, Inc. (AVOP), is a publicly traded investment and holding company established to identify, secure and monetize emerging growth companies in a number of sectors that include cannabis related technologies, grow houses and cultivation, and e-commerce businesses positioned for exponential growth. After identifying businesses displaying revolutionary concepts able to develop a substantial footprint in high-growth markets, the business model followed calls for incubating and supporting the best opportunities.

The company seeks to discover inspired entrepreneurs with innovative ideas that are poised for significant revenue generation. Management expertise can be seen in the development of embryonic-stage subsidiaries as the company brings a spectrum of backgrounds to the table with a significant resource of knowledge and experience to every venture. AV1 Group explores every opportunity to help each sector exceed its revenue goals while building close, active working relationships as it prepares each respective division to be a robust competitor within the various chosen markets.

AV1 Group companies include:

  • XFIRESmartSystems.com – Intelligent lighting solutions and wireless access for many different applications.
  • VaporHighUSA.com – Over 800 vaping products; bitcoin payments accepted.
  • DentalCannatizer.com – Revolutionary dual jet dental water jet integrates hemp oil infusing.
  • IntelligentLightingCorp.com – Comprehensive, energy-efficient lighting solutions.
  • CannaLighting.com – Wholly owned subsidiary building strategic relationships in the LED sector to provide solutions for grow houses and cultivation centers.
  • MJIQ – First, comprehensive, enterprise-grade integrated software suite being developed for the legal cannabis industry.
  • Hemptory.com – Engaging online destination for all hemp and cannabis related products and services.
  • Lawster.com – Puts consumers and small businesses in contact with legal services and service providers.
  • MJTestLabs.com – Under development website will serve cannabis dispensaries, laboratories and industry affiliates.

AV1 Group's business model delivers an advantage with internally-created projects that are poised for revenue generation and a cross-company revenue platform that enables the company to incubate and foster growth in early-stage subsidiaries under one umbrella. Disclaimer

AV1 Group, Inc. Blog

AV1 Group, Inc. News:

AV1 Group Announces Purchase Order from an Additional California Prison

AV1 Group, Inc. (AVOP) Engages NetworkNewsWire for Corporate Communications Solutions

AV1 Group Announces Pilot for SMART transition of a Major Michigan City for $5.5 Million

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.056, up 11.33%, on 121,458 volume with 16 trades. The stock’s average daily volume over the past 60 days is 153,229 and its 52-week low/high is $0.003/$0.33.

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare ® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

New Skinvisible, Inc. (SKVI) Subsidiary Signs Exclusive License Agreement to Distribute Its Topical Cannabis Products in the USA

Skinvisible, Inc. (SKVI) Engages NetworkNewsWire for Corporate Communications Solutions

Skinvisible, Inc. (SKVI) is “One to Watch”

Algae Dynamics Corp. (ADYNF)

The QualityStocks Daily Newsletter would like to spotlight Algae Dynamics Corp. (ADYNF). Today, Algae Dynamics Corp. closed trading at $0.10, up 11.11%, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 7,942 and its 52-week low/high is $0.0001/$0.62.

Algae Dynamics Corp. (ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae.

The original core of the company's product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives to marijuana consumption will help support ongoing initiatives to create and market research-driven product formulations.

Although the company is publicly traded in the U.S., business is conducted in Canada with no exposure to U.S. federal regulation involving cannabis. The Canadian cannabis oil extraction marketplace is projected to grow from C$1 million in 2015 to C$1.7 billion in 2020, which is more than a 1,000-fold increase. With the Government of Canada indicating a target date for full legalization on or before July 2018, numerous opportunities for sales in extracts and oils will open up very soon.

Using Colorado as a comparable example, a study performed by Mackie Research Capital found that 45% of dried marijuana users in the state would eventually convert to marijuana extracts and oils. This is because most consumers taking cannabis for medical purposes are increasingly looking for delivery systems that do not involve smoking marijuana. The market's attractiveness can be further realized when considering that the Canada's licensed producer marketplace is far less competitive with 45 current licensed producers for the whole country vs. 624 licensed cultivators in Colorado.

Collaborating with prominent Canadian universities is a core part of the Algae Dynamics' plan to bolster cannabis extraction expertise, develop premium products and add to its portfolio of intellectual property. Through its agreements with the University of Waterloo and the University of Western Ontario, the company is focusing primarily on the use of extracts from cannabis oil and algae oil in the context of cancer as well as the development of new pharmacotherapies for mental health.

Near-term goals include expanding research and development work with existing and new Canadian universities, securing supply/service agreements with licensed producers, and submitting an application to Health Canada to become a licensed producer of medical marijuana and ultimately have a license to sell products derived from cannabinoids. Algae Dynamics also owns a proprietary technology for the cultivation of low cost, highly pure algae biomass, which will be developed as a vertical integration strategy in the future to support the need to source algae oil for research-driven product formulations. The management team leading these initiatives has nearly a century of beneficial experience spanning from management and process experience to successful fund raising and commercialization.

As part of its key objective to be the #1 research Canadian cannabis oil research-driven product formulator, the company has also formed a strong team of scientific and strategic advisors that complement ongoing R&D relationships and initiatives. Individuals who support the company's initiatives include Dr. Jonathan Blay PhD, FRSB, FIBMS, Csci, CBiol, who performs research and product development on cannabis oil and its constituents in the context of colorectum, pancreas, breast and prostate cancers; and Dr. Steven Laviolette, BSc, PhD, who performs research and product development on cannabis oil and its constituents in the context of depression, post-traumatic stress disorder, anxiety and schizophrenia.

With such a strong foundation laid in the areas being pursued, Algae Dynamics is well positioned to execute on its carefully developed business plan to fast-track to revenue growth while having a longer-term strategy to build a sustainable enterprise-building opportunity in a rapidly expanding market. Disclaimer

Algae Dynamics Corp. Blog

Algae Dynamics Corp. News:

Algae Dynamics Corp Announces C$400,000 Research Grant from Mitacs To Support Cannabis Research With University Of Western Ontario

Algae Dynamics Corp Secures Us $250,000 Investment from Teewinot Life Sciences Corporation

Algae Dynamics Corp Enters Into a Letter of Intent with Bonify to Produce Unique Cannabis Oil Products; Accelerates Go-to-Market Strategy

RJD Green Inc. (RJDG)

The QualityStocks Daily Newsletter would like to spotlight RJD Green Inc. (RJDG). Today, RJD Green Inc. closed trading at $0.0082, up 9.33%, on 85,000 volume with 4 trades. The stock’s average daily volume over the past 60 days is 1,796,219, and its 52-week low/high is $0.0031/$0.029.

RJD Green Inc. (RJDG) is a holding company with a focus on acquiring and managing assets and companies in three divisions. These initial high-growth enterprise opportunities offer diversity in separate recession resistant markets. The division holdings include:

  • RJD Green Healthcare Services – provides services to reduce cost and enhance management and operational capabilities in the healthcare sector.
  • Earthlinc Environmental Services – provides green environmental services and technologies.
  • Silex Holdings – acquires specialty construction and industrial manufacturing assets.

RJD Green Healthcare Services, through its wholly owned subsidiary IOSOFT Inc., provides proprietary software and IT support for medical billing, healthcare claims adjudication, and electronic payments between healthcare payers and providers. IOSOFT's unique payment technologies and services or software can be integrated with existing systems of healthcare payers such as Blue Cross, Aetna, CIGNA and others. IOSOFT provides targeted offerings for healthcare providers, provider networks, physicians and hospitals, and clearinghouse companies.

Earthlinc Environmental Solutions was formed to bring forward green-applied technologies and offer environmental services with a focus on North America. The division's first acquisition, Animal Waste Management, is launching operations of a patented, fully developed technology for processing waste produced on commercial poultry and hog farms. Development of this technology was supported by the University of Arkansas and the Missouri Department of Natural Resources. This important technology improves the farm's productivity and is competitively priced with the current expense of handling waste removal at these sites.

The company's third division – Silex Holdings Inc. – was formed to acquire and manage high-growth assets and business enterprises in the industrial and construction specialty services sectors. With its first acquisition of Silex Interiors, a manufacturer, distributor and installer of counter tops, cabinets and related kitchen and bath products, the division is poised to expand into major national markets through internal expansion, acquisition and franchising. The company is modeled to operate a minimum of four corporately owned locations with 12 to 18 franchise locations nationwide.

RJD Green seeks to participate as owners, partners or in joint ventures in a wide range of business enterprises. The company's goal of creating a successful, enjoyable business enterprise for its company team and staff, along with its business partners and investors, is paired with the goal of maximizing the business potential of the enterprise by enhancing profits and the quality of the company. Disclaimer

RJD Green Inc. Company Blog

RJD Green Inc. News:

RJD Green, Inc. Updates Progression of Animal Waste Management and 2017 10K Filing

RJD Green Inc. Appoints Director

RJD Green Inc. Subsidiary, IOSOFT, Discusses Contracts Procured and Revenue Expectations


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters



(ACST) +144.08%


(HPIL) +45.00%


Penny Pick Finders
(HMPQ) +44.97%

By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251